Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Sep 26, 2022
Date Accepted: Feb 19, 2023
Date Submitted to PubMed: Feb 27, 2023

The final, peer-reviewed published version of this preprint can be found here:

Development of a Mobile App to Monitor the Effectiveness of a Hydrolyzed Cartilage Matrix Supplement on Joint Discomfort: Real-World Study

Newman C, Adriaens E, Virgilio N, Vleminckx S, de Pelsmaeker S, Prawitt J, Silva CI

Development of a Mobile App to Monitor the Effectiveness of a Hydrolyzed Cartilage Matrix Supplement on Joint Discomfort: Real-World Study

JMIR Form Res 2023;7:e42967

DOI: 10.2196/42967

PMID: 36848035

PMCID: 10131938

Development of a mobile application to monitor the effectiveness of a hydrolyzed cartilage matrix supplement on joint discomfort: a real-life study

  • Christie Newman; 
  • Els Adriaens; 
  • Nicolina Virgilio; 
  • Sara Vleminckx; 
  • Sara de Pelsmaeker; 
  • Janne Prawitt; 
  • Catarina I.F. Silva

ABSTRACT

Background:

Protocols assessing the effect of a nutritional intervention on health commonly involve a series of face-to-face meetings between participants and study staff that can weigh on resources, participant availabilities and even increase dropout rates. Digital tools are increasingly added to protocols to facilitate study conduct but fully digitally run studies are still scarce.

Objective:

The purpose of the current real-life consumer study was to develop a mobile application to conduct a 100% digital study testing the efficacy of a hydrolyzed cartilage matrix supplement on joint discomfort in a heterogeneous group of active consumers.

Methods:

A mobile app using Visual Analog Scale (VAS) was specifically developed to monitor the variation in joint pain after exercise by the study participants. A total of 201 healthy and physically active adult women and men (18 to 72 years old) with joint pain completed the consumer study over a period of 16 weeks. Participants blindly received study supplements and took a daily regimen of 1 g of hydrolyzed cartilage matrix (HCM-G) or 1g of maltodextrin (placebo group; P-G) for 12 weeks while weekly logging joint pain scores in the app, followed by a wash out period during which participants continued reporting their joint pain scores until the end of week 16.

Results:

Joint pain was reduced within 3 weeks of taking a low dosage of HCM (1g/day), regardless of gender, age group and activity intensity. After stopping supplementation, joint pain scores gradually increased but still remained significantly lower than placebo after 4 weeks of washout.

Conclusions:

Overall, the current investigation showed the value of using digital tools for consumer research and confirmed that the oral intake of a hydrolyzed cartilage matrix led to a reduction of joint pain in active adults of different age groups and lifestyles in a real-life setting.


 Citation

Please cite as:

Newman C, Adriaens E, Virgilio N, Vleminckx S, de Pelsmaeker S, Prawitt J, Silva CI

Development of a Mobile App to Monitor the Effectiveness of a Hydrolyzed Cartilage Matrix Supplement on Joint Discomfort: Real-World Study

JMIR Form Res 2023;7:e42967

DOI: 10.2196/42967

PMID: 36848035

PMCID: 10131938

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.